Stable Istotope Labelled Romilkimab Biosimilar – Anti-IL13/IL4 mAb – Research Grade
Size | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Stable Istotope Labelled Romilkimab Biosimilar - Anti-IL13/IL4 mAb - Research Grade |
---|---|
Source | IMGT/mAb-DB 794 |
Species | Human |
Expression system | Mammalian cells |
Molecular weight | LC: 36kDa HC: 63kDa |
Purity | >95% |
Buffer | PBS pH7.5 |
Delivery condition | Blue Ice |
Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
Storage condition | 4°C for short term; -20°C for long term |
Brand | ProteoGenix |
Aliases /Synonyms | Romilkimab |
Reference | PX-TA1027-SIL |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | [VH-VH' Gamma1 + VL-VL' kappa (bispecific) |
Clonality | Monoclonal Antibody |
Format | Lyophilized |
Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99% |
Isotopic Enrichment | 99% |
Stability | 1 year |
General information about Romilkimab
Romilkimab is an engineered, humanised, bispecific immunoglobulin-G4 antibody that binds and neutralizes IL-4/IL-13 making it ideal for exploration in fibrosis, This product is for research use only.
Contact us
Send us a message from the form below
Reviews
There are no reviews yet.